FCA fines Commerzbank London £37,805,400 over anti-money laundering failures

18 June 2020

The Financial Conduct Authority (FCA) has today fined Commerzbank AG (London Branch) £37,805,400 for failing to put adequate anti-money laundering (AML) systems and controls in place between October 2012 and September 2017. Commerzbank London was aware of these weaknesses and failed to take reasonable and effective steps to fix them despite the FCA raising specific concerns about them in 2012, 2015 and 2017. These weaknesses also persisted during a period when the FCA was publishing guidance on steps firms could take to reduce financial crime risk as well as taking enforcement action against a number of firms in relation to AML controls. Despite these clear warnings, the failures continued. Continue reading…

Financial policymakers discuss responses to COVID-19 with the private sector

16 June 2020

Financial policymakers and international standard setters recently met virtually with private sector executives to discuss international policy responses to COVID-19. Organised by the FSB’s Standing Committee on Supervisory and Regulatory Cooperation (SRC), in cooperation with Basel Committee on Banking Supervision (BCBS), the Committee on Payments and Market Infrastructures (CPMI), the International Association of Insurance Supervisors (IAIS) and the International Organisation of Securities Commissions (IOSCO), the meeting brought together senior representatives from central banks, regulatory authorities and finance ministries as well as about 30 international banks, insurance firms, asset managers, market infrastructures and credit rating agencies. Continue reading…

FCA fines Lloyds Bank, Bank of Scotland and The Mortgage Business for failures in mortgage arrears handling

15 June 2020

The Financial Conduct Authority (FCA) has recently fined Lloyds Bank plc, Bank of Scotland plc and The Mortgage Business plc (“the banks”) £64,046,800 for failures in relation to their handling of mortgage customers in payment difficulties or arrears. The banks have estimated that they will have paid approximately £300 million in redress. The redress programme is nearly complete. Continue reading…

Planning and executing audit engagements in times of Covid-19: core points of focus and practical solutions

12 June 2020
Knowledge Base

by Alex Movchan

We have recently had the pleasure of speaking with Olga Lukashenko who is an Audit Director at Reanda Netherlands. She is an incredibly dedicated finance professional with experience in accounting, auditing and financial management. She also has a proven track record in preparation of consolidated financial statements according to IFRS and GAAP, IFRS-reporting implementation in different accounting systems, as well as auditing and independent assessment of financial and non-financial data. Olga has an impressive international career with in depth knowledge of audit practices. This year is very unusual in terms of the Covid-19 related situation and many Chief Audit Executives struggle to execute the audit plans given travel restrictions, additional limitations of resources and shifting business priorities.  Continue reading…

The EU Recovery Plan: an upcoming webinar on EU Member States recovering in a cooperative and resilient manner from the Covid-19 crisis

10 June 2020

We are all living in an extraordinary crisis with the Covid-19 pandemic. While the virus has affected every Member State, the budgetary capabilities of each state’s response to the crisis is not equivalent. Countries that have not fully recovered can have a negative impact on the economic growth of other Member States that have been able to escape the grasps of Covid-19 quicker. This is why cooperation and taking the same measures within the European Union is essential to guarantee that the single market, which is the bedrock of the European economy, does not collapse. Continue reading…

Regxsa empowers financial institutions in taking responsibility towards society and doing the right thing

08 June 2020

by Dina-Perla Portnaar

Regxsa, formerly known as AMLabc, empowers financial institutions in taking responsibility towards society and doing the right thing. The company launches the cloud based solution Alexis to bring back the human factor in the heart of the fight against money laundering, terrorism financing and related financial crimes. Regxsa supports financial institutions to meet local and global regulatory requirements. The company also aims at achieving and exceeding regulatory expectations and doing the right thing for society, through advisory services, training, placement and cloud based AML investigations. The company launched the SaaS (Software-as-a-Service) investigation tool Alexis with top software development company Fortech in 2020. Continue reading…

How can banks project losses in the current Covid-19 crisis?

05 June 2020

Global Credit Data (GCD) recently published its 2020 report on Loss Given Default (LGD), which offers the latest numerical evidence of recoveries and losses incurred by banks from loans to large corporate borrowers. Global Credit Data is a non-profit association whose mission is to help banks better understand and model their credit risks through data pooling and benchmarking activities. In turn, the report is based on a clear and qualified set of data, underpinned by verified, high-quality information collected over 15 years from more than 60 global and regional banks. What’s more, this year’s edition represents the first complete account of the losses incurred during the global financial crisis of 2008. Continue reading…

Photo: Doctor Man With Stethoscope In Hospital

Institutional construction of reality, bounded rationality & compliance: lessons to be learned from Covid-19

03 June 2020
Knowledge Base

by Massimo Balducci

It is time to start some evaluation of institutional responses to Covid-19 emergency. Two questions need to be answered in this first evaluation: (a) was the emergency rightly evaluated or was it under- or over- evaluated? And (b) was the medical response correct and was it possible to adjust it via a trial and error approach? Our hypothesis here is that a misleading institutional construction of reality and weaknesses in the management of information might have caused harm possibly greater than the very virus itself. Was the emergency under- or over-evaluated? Continue reading…

Covid-19 and Solvency II – No time to lose

01 June 2020

by Lieve Lowet

This is the last part of a series of three articles about my investigation into Covid-19 and Solvency II. We have already published two interesting blogs, which can be found in the related items section. The first part was about buying time and data and the second part was about the Covid-19 pandemic risk. In the light of the Solvency II review, one question is whether pandemic risk is adequately dealt with in the solvency capital requirements. Are the calibrations and parameters in the life and health underwriting risk submodules for catastrophic risk still in line with the (new) insights and observations of a worldwide pandemic, such as COVID-19? And if not, is an adaptation necessary? Are additional parameters required?   Continue reading…

Lieve Lowet

Lieve Lowet

EU Affairs consultant and lobbyist

Covid-19 and Solvency II: Where is the pandemic risk?

29 May 2020

by Lieve Lowet

This is the second part in a series of three articles written by me, which focuses on the Covid-19 pandemic risk. Today, examining the Solvency II framework, pandemic risk is a submodule considered in the health catastrophe risk module, consisting of a mass accident risk submodule, an accident concentration risk submodule, the latter including worker’s compensation insurance, and a pandemic risk submodule (Art 160-163, DEA). According to Article 163 of the Solvency II delegated regulation, the pandemic risk submodule covers the medical expense pandemic exposure and the income protection pandemic exposure but not workers compensation insurance. Annex XVI includes the different factors to be used in that module, such as the ratio of insured persons with clinical symptoms, which are hospitalised (1%), consult a medical practitioner (20%) or seek no formal medical care (79%).  Continue reading…